Clinical and laboratory features of Mycobacterium avium complex infection in comparison with infection, caused by Mycobacterium tuberculosis, in HIV-infected patients Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II Year: 2019
Study of genetic heterogeneity in Mycobacterium tuberculosis isolates from tuberculosis patients using DNA fingerprinting Source: Eur Respir J 2005; 26: Suppl. 49, 655s Year: 2005
Clinical relevance of Mycobacterium malmoense isolation in the Netherlands Source: Eur Respir J 2009; 34: 926-931 Year: 2009
Genotyping of human Mycobacterium kansasii isolates from Poland. Source: International Congress 2017 – Microbiology and laboratory techniques to monitor NTM infections Year: 2017
On the nature of Mycobacterium tuberculosis-latent bacilli Source: Eur Respir J 2004; 24: 1044-1051 Year: 2004
Investigation of the inhibition of adherence of Mycobacterium avium complex (MAC) and Mycobacterium tuberculosis (MTB) to the respiratory mucosa Source: Eur Respir J 2001; 18: Suppl. 33, 480s Year: 2001
Transmission of Mycobacterium tuberculosis to households of tuberculosis patients Source: Eur Respir J 2005; 26: Suppl. 49, 197s Year: 2005
Infection of the respiratory mucosa by Mycobacterium avium complex (MAC), Mycobacterium tuberculosis (MTB) and Mycobacterium smegmatis (MS) Source: Eur Respir J 2001; 18: Suppl. 33, 308s Year: 2001
Lung function evolution in patients with microbiological isolation of Mycobacterium abscessus Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection Year: 2019
Isolation of M. abscessus from patients with M. avium complex (MAC) lung disease Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections Year: 2013
Express detection and differentiation of M. tuberculosis and nontuberculous mycobacteria in samples Source: International Congress 2017 – MDRTB: detection and management Year: 2017
Mycobacterium tuberculosis DNA detection in urine samples from pulmonary tuberculosis patients Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis Year: 2008
Drug resistance of Mycobacterium tuberculosis isolated from tuberculosis inflammatory foci Source: Eur Respir J 2005; 26: Suppl. 49, 654s Year: 2005
Pulmonary diseases caused by non-tuberculous mycobacteria Source: Eur Respir Mon 2012; 58: 25-37 Year: 2012
Evaluation of a IFN-γ test using Mycobacterium tuberculosis -specific antigens for diagnosis of active tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 142s Year: 2006
Discriminating active from latent tuberculosis by Mycobacterium tuberculosis (MTB)-peptide specific immunoresponses Source: Annual Congress 2008 - Priorities for tuberculosis research in Europe: discussing the results of the Tuberculosis Network European Trials Group (TBNET) Year: 2008
Importance of identifying Mycobacterium bovis as a causative agent of human tuberculosis Source: Eur Respir J 2010; 35: 692-694 Year: 2010
Annual risk of infection with Mycobacterium tuberculosis Source: Eur Respir J 2005; 25: 181-185 Year: 2005
Outcomes of Mycobacterium avium complex lung disease based on clinical phenotype Source: Eur Respir J, 50 (3) 1602503; 10.1183/13993003.02503-2016 Year: 2017
Lymphocyte responses to Mycobacterium tuberculosis and Mycobacterium bovis are similar between BCG-vaccinated patients with cystic fibrosis and healthy controls Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis Year: 2020